ACCURATE INTRAPARTUM ESTIMATION OF FETAL PLATELET COUNT BY FETAL SCALP SAMPLE SMEAR

被引：17

作者：

ADAMS, DM

BUSSEL, JB

DRUZIN, ML

机构：

[1] Departments of Obstetrics and Gynecology and Pediatrics, The New York Hospital/Cornell Medical Center, New York

来源：

AMERICAN JOURNAL OF PERINATOLOGY | 1994年 / 11卷 / 01期

关键词：

D O I：

10.1055/s-2007-994534

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Fetal scalp sampling has been used to determine fetal platelet count in early labor. Because platelet clumping may lead to falsely low platelet counts, this pilot study was carried out to evaluate an improved method of scanning an intrapartum fetal scalp smear for platelet estimation. We report 5 years' experience with the use of scanning of the smear for platelet aggregates instead of direct measurement of platelets. In 22 cases, intrapartum examination of the scalp blood smear at low power revealed the great majority of high-power, dry microscope fields devoid of platelets, whereas isolated fields contained aggregates of more than 10 platelets. In one case, an adequate number of platelets were evenly distributed. Intrapartum fetal platelet estimation by scanning of the smear (using these platelet aggregates) correctly identified an adequate neonatal platelet count in 23 cases (mean, 264,600 +/- 15,000; range, 133,000 to 396,000). Cesarean section was avoided in 82.6% of these cases. In this pilot study, platelet estimation on fetal scalp sample was reliably performed by scanning of the smear for platelet aggregates. When aggregates were seen, platelet adequacy was found in all cases.

引用

页码：42 / 45

页数：4

共 19 条

[1]

Keiton J.G., Management of the pregnant patient with idio pathic thrombocytopenic purpura, Ann Intern Med, 99, pp. 796-800, (1983)

[2]

Samuels P., Bussel J.B., Brahman L.E., Et al., Estimation of the risk of thrombocytopenia in the of fspring of pregnant women with presumed immune thrombocytopenic purpura, N Engl J Med, 323, pp. 229-235, (1990)

[3]

Bussel J.B., Druzin M.L., Cines D.B., Samuels P., Thrombocytopenia in pregnancy, Lancet, 337, (1991)

[4]

C#x0027

[5]

arloss H.W., McMillan R., Crosby W.H., Management of pregnancy in women with immune thrombocytopenic purpura, JAMA, 244, pp. 2756-2758, (1980)

[6]

Hart D., Dunetz C., Nardi M., Porges R.F., Weiss A., Karpatkin M., An epidemic of maternal thrombocytopenia associated with elevated antiplatelet antibody, Am J Obstet Gynecol, 154, pp. 878-882, (1986)

[7]

Burrows R.F., Kellon J.G., Incidentally detected thrombocytopenia in healthy mothers and their infants, N Engl J. Med, 319, pp. 142-145, (1988)

[8]

Cook R.L., Millet R.C., Katz V.L., Cefalo R.C., Immune thrombocytopenic purpura in pregnancy: A reappraisal of management, Obstet Gynecol, 78, pp. 578-583, (1991)

[9]

Burrows R.E., Kellon J.G., Low fetal risks in pregnancies associated with idiopathic thrombocytopenic purpura, Am J Obstet Gynecol, 163, pp. 1147-1150, (1990)

[10]

Daffos F., Capella-Pavlovsky M., Forestier F., Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: A study of 606 consecutive cases, Am J Obstet Gynecol, 153, pp. 655-660, (1985)

← 1 2 →